• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » The critical importance of an effective data strategy for EU MDR

The critical importance of an effective data strategy for EU MDR

September 30, 2019 By Sponsored Content

The deadline for the new European Medical Device Regulation (EU MDR) is just around the corner. Are you ready?

By now, your organization has probably conducted a portfolio review and assessment. You might have even progressed to your Clinical Evaluation Report. But during the assessment process, you may have discovered significant data gaps. You might find yourself struggling to prove the safety of your device. What now?

The Challenges of EU MDR

The new EU MDR represents a significant regulatory change for medical device manufacturers.  These updated regulations are designed to track the safety and efficacy of products. As of May 2020, manufacturers and distributors must show clinical evidence on the safety of every Class III device in their portfolio. This clinical evidence will face heavy scrutiny. If your data isn’t up to scratch, your company could be in trouble.

With the new EU MDR, your data will also need recurring updates. A single pre-approval review is no longer enough. Instead, new EU MDR promotes a lifecycle approach to medical device regulation. Companies must continue collecting and analyzing data after their device hits the market.

Any company that hopes to sell within the EU will also need a robust Post-Market Surveillance (PMS) system. This system must cover all the medical devices your company manufactures. Your PMS system must include a Post-Market Clinical Follow-up (PMCF) to help your company meet the EU MDR targets. PMCF facilitates quality, performance, and safety data collection throughout the device’s lifetime.

SaaS to the Rescue

Meeting EU MDR targets is achievable with robust, dynamic, and easy-to-use software. To achieve new data-collection goals, most companies will need to upgrade their software. These upgrades reflect the growing industry need for post-clinical device tracking. The right software system is an invaluable tool throughout this process.

When developing your data-collection strategy and searching for new software, consider the following:

  • Data Collection
    Under the new EU MDR, your company will collect more data than ever. You will need a robust system that can keep track of many data streams.
  • Data Systems
    A robust collection of data is useless if there’s no system to make sense of it. You need software that categorizes data, leaving vital information at your fingertips.
  • Data Quality
    An effective software system and data platform allows you to sift through mountains of data quickly. With an upgraded system, you can easily see which devices are most effective and which need further attention.
  • Data Analytics
    An AI-enhanced software can make recommendations for treatment strategies and follow-up care. AI helps your organization crunch large volumes of data to identify treatment patterns. This software can even flag abnormal responses or identify the need for clinical interventions.
  • Data People
    Clinicians, patients, researchers, manufacturers, and government organizations will need a share in your data. Therefore, developing a central database is essential. A robust database ensures that all stakeholders can access the information they need.
  • Data Privacy
    To maintain your company’s license to operate and preserve your global reputation, you need software with a rigid security protocol. The right system has strict safeguards to protect client and patient privacy.

Where Does Real World Evidence Play a Role?

Once, medical devices were sent out into the world and then, often forgotten. Manufacturers frequently neglected to follow up with their patients. Little data was gathered about how patients tolerated their devices. Side effects and real-world patient practices often went unnoticed.

The new EU MDR aims to solve this problem. Manufacturers will now be required to gather real-world data (RWD) and real-world evidence (RWE) for all their devices. These two terms may seem confusing at first, but their relationship is easy to understand. RWD is gathered from patient surveys, clinical trials, and cohort studies. Once you have plenty of data, you can analyze it to draw conclusions about the risks and benefits of your medical device. These conclusions are considered RWE.

Tracking is an essential part of gathering RWD. Under EU MDR, each device will be tracked through the use of unique device identification (UDI). UDIs allow your company to record incident reports, institute recalls, and reduce medical errors. Your company can also receive real-time data about how your devices operate in the hands of patients.

RWD offers countless opportunities for device improvement. Gathering data from diverse patient groups allows you to learn which areas of your device need improvement. During the RWD-collection process, you may notice that a certain device isn’t working the way it should. Reconfiguring the device can spark innovation and lead to new developments in your company’s product catalog. Over time, these innovations can boost your company’s bottom line.

With UDIs, patients can also enjoy safer, more effective devices. But UDIs generate a tremendous amount of data that your company will need to track. Once again, a robust solution, such as those offered by SHYFT Analytics, a Medidata company, can be your saving grace. SHYFT helps your company convert data into clear, concise insights. With SHYFT, you can use your data to drive clinical development and achieve even greater success.

Thousands of companies are striving to meet the new EU MDR. But many have struggled to find a strategy that meets their needs. If your company is overwhelmed by increased demand for data, consider a new technology solution. The right system can streamline the data collection and distribution process. Efficient software ensures that your company thrives under the new EU MDR.

To learn more about how Medidata and SHYFT Analytics can help, visit us at https://www.medidata.com/en/shyft-analytics/.

Sources:

Medidata. The Rise of Integrated Data in Medical Devices. https://www.medidata.com/wp-content/uploads/2019/05/White-Paper-The-Rise-of-Integrated-Data-in-Medical-Device-May-19-1-1.pdf (Accessed September 9, 2019)

Deloitte. Preparing for the Future: The New European Union Medical Devices Regulation. https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-eu-med-device-regulation.pdf (Accessed September 9, 2019)

Medical Product Outsourcing. 4 Ways to Prepare for the European Medical Device Regulation (MDR) https://www.mpo-mag.com/issues/2019-01-01/view_columns/4-ways-to-prepare-for-the-european-medical-device-regulation-mdr (Accessed September 9, 2019)

Medicines & Healthcare Products Regulatory Agency. Use of Real World Evidence under European MDR. https://www.pmda.go.jp/files/000221793.pdf (Accessed September 9, 2019)

Duke University. Opportunities and Gaps in Real-World Evidence for Medical Devices. https://healthpolicy.duke.edu/sites/default/files/atoms/files/rwe_medical_devices_meeting_summary.pdf (Accessed September 9, 2019)

Sponsored content by Medidata Solutions

Filed Under: Sponsored Content Tagged With: Medidata Solutions

In case you missed it

  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS